Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 11;6(6):804-812.
doi: 10.1002/ags3.12578. eCollection 2022 Nov.

Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases

Affiliations

Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases

Yoshiaki Tanji et al. Ann Gastroenterol Surg. .

Abstract

Introduction: The purpose of this study was to investigate the relation between preoperative cachexia index (CXI) and long-term outcomes in patients with colorectal liver metastases (CRLM) after hepatic resection.

Method: In all,118 patients who underwent hepatic resection for CRLM were analyzed retrospectively. The relationship between CXI and the long-term outcomes in patients after hepatic resection was investigated. CXI was calculated based on preoperative skeletal muscle index, serum albumin level, and neutrophil-lymphocyte ratio.

Results: The multivariate analysis showed that extrahepatic lesion (hazard ratio [HR] 2.86, 95% confidence interval [CI] 1.48-5.53, P < .01) and high CXI (HR 0.44, 95% CI 0.20-0.98, P = .04) were independent and significant predictors of disease-free survival. Moreover, extrahepatic lesion (HR 2.32, 95% CI 1.03-5.22, P = .04), high CXI (HR 0.17, 95% CI 0.05-0.57, P < .01), and curability R 1 or 2 (HR 3.29, 95% CI 1.23-8.78, P = .02) were independent and significant predictors of overall survival.

Conclusion: CXI is a useful prognostic factor for disease-free survival and overall survival after hepatic resection in CRLM patients.

Keywords: cachexia; colorectal liver metastases; liver resection.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) Kaplan–Meier curve for disease‐free survival after hepatic resection for colorectal liver metastasis. (B) Kaplan–Meier curve for overall survival after hepatic resection for colorectal liver metastasis

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Katanoda K, Kamo K, Saika K, Matsuda T, Shibata A, Matsuda A, et al. Short‐term projection of cancer incidence in Japan using an age‐period interaction model with spline smoothing. Jpn J Clin Oncol. 2014;44(1):36–41. - PubMed
    1. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9. - PMC - PubMed
    1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982–99. - PMC - PubMed
    1. Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3(1):50–6. - PMC - PubMed

LinkOut - more resources